taXonomy Pathways builds on the most comprehensive, consistent, and curated claims resource, interoperable with labs, EHR, and more, to deliver disease-specific datasets that offer efficiency across multiple indications, flexibility to focus on the most relevant labs, and depth to unlock richer insights across the full patient journey.
Join Alexa Woodward, PhD, Associate Director of Strategic Accounts, and Veronica Ansolabehere, Director of Data Product Management, on October 16th at 12:00 p.m. ET to see how taXonomy Pathways can accelerate your Q4 initiatives and deliver Verified insights that competitors can’t match.
What you’ll learn:
- How you can combine closed claims with EMR, labs, clinical notes, and imaging to deliver interoperable, regulatory-trusted evidence
- Several therapy areas that can benefit most from pre-built, disease-specific datasets before year end
- How taXonomy Pathways helps you maximize year-end budgets while preparing 2025-ready evidence for regulatory, payer, and HEOR needs